CCR5 and inflammatory bowel disease: The reduction was around 16.8% in the case of CCR5+ (Figures 2C) and around 15.8% in the case of RORγT+ (Figures 2F) RORγT+ cells were readily detectable in healthy non-IBD-induced animals (Figures 2D, E).